The Recall Desk
SevereFDA (Drugs)·D-1623-2020·Announced 2020-09-30

Preferred Pharmaceuticals Recalls Nature-Throid Tablets Due to CGMP Deviations

Preferred Pharmaceuticals is voluntarily recalling specific lots of Nature-Throid tablets due to Current Good Manufacturing Practice (CGMP) deviations. The affected repackaged tablets were sold to three physicians in California and Georgia.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, if the agency's own classification is FDA Class I or USDA Class I, the score is never below 4; however, FDA Class II recalls involving significant potential risks or structural defects are typically scored as 4 (Severe) to reflect the higher risk compared to Class III, especially when specific manufacturing deviations are cited without immediate reported fatalities.

Plain-English summary

Preferred Pharmaceuticals, Inc. is voluntarily recalling Nature-Throid, 1 Grain, 65 mg tablets. The recall was initiated on September 2, 2020, and was classified as Class II by the FDA. The reason for the recall is Current Good Manufacturing Practice (CGMP) deviations.

The affected product includes 90-count bottles (NDC 68788-7604-09) and 100-count tablets (NDC 68788-7604-01). The specific lots involved are A0220Q and K15171, both with an expiration date of 10/31/2020. The tablets were manufactured by RLC Labs in Cave Creek, AZ, and repackaged by Preferred Pharmaceuticals.

The distribution pattern indicates that the repackaged tablets were sold to three physicians located in California and Georgia. The recall status is currently Terminated, with a termination date of April 25, 2024. Consumers and healthcare providers should check their inventory for these specific lot numbers and NDC codes.

The recalled product

Product
Nature-Throid, 1 Grain, 65 mg (Thyroid U.S.P. 1 gr. (65mg)/Liothyronine (T3) 9mcg/Levothyroxine (T4) 38mcg, packaged in a) 90-count bottles (NDC 68788-7604-09), b) 100-count tablets (NDC 68788-7604-01), Rx Only, Mfg: RLC Labs; Cave Creek, AZ, Preferred Pharmaceuticals, Inc.
Manufacturer
Preferred Pharmaceuticals, Inc.
Category
Drug — Thyroid Hormone
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • a) Lot #: A0220Q
  • Exp. Date: 10/31/2020
  • b) Lot #: K15171

Distribution

Distributed in 2 states:

Part of a larger recall action

This product is one of 4 recalled by Preferred Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 4 products in this recall →

Related recalls

Same manufacturer · Preferred Pharmaceuticals, Inc.

See all →

Same hazard · cgmp deviations

See all →